STE vs. BSX
STE (STERIS plc) and BSX (Boston Scientific Corporation) are both stocks. Both operate in the Medical Devices industry within the Healthcare sector. Over the past 10 years, STE returned 13.57%/yr vs 7.21%/yr for BSX. Their 0.30 correlation means their historical movements had little consistent relationship.
Performance
STE vs. BSX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, STE achieves a -7.73% return, which is significantly higher than BSX's -49.21% return. Over the past 10 years, STE has outperformed BSX with an annualized return of 13.57%, while BSX has yielded a comparatively lower 7.21% annualized return.
STE
- 1D
- 1.86%
- 1M
- 6.62%
- 6M
- -11.47%
- YTD
- -7.73%
- 1Y
- 3.63%
- 3Y*
- 1.98%
- 5Y*
- 2.42%
- 10Y*
- 13.57%
- ALL TIME*
- 16.37%
BSX
- 1D
- 3.64%
- 1M
- 7.29%
- 6M
- -47.28%
- YTD
- -49.21%
- 1Y
- -54.06%
- 3Y*
- -1.53%
- 5Y*
- 1.82%
- 10Y*
- 7.21%
- ALL TIME*
- 7.37%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $1.07B | $853.65M | $1.01B | |
STE STERIS plc | $160.88M | $157.15M | $177.32M |
STE vs. BSX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
STE STERIS plc | -7.73% | 24.57% | -5.60% | 20.19% | -23.43% | 29.47% | 25.50% | 44.09% | 23.66% | 31.73% |
BSX Boston Scientific Corporation | -49.21% | 6.75% | 54.51% | 24.94% | 8.92% | 18.16% | -20.50% | 27.96% | 42.56% | 14.61% |
Correlation
The correlation between STE and BSX is 0.38, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.38 |
Correlation (3Y) Balances recent behavior with more history. | 0.36 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.46 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.48 |
Correlation (All Time) Calculated using the full available price history since Jun 1, 1992 | 0.30 |
The correlation between STE and BSX shifts across timeframes, from 0.30 (all time) to 0.48 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
STE:
$22.67B
BSX:
$71.98B
STE:
$7.93
BSX:
$2.46
STE:
29.34
BSX:
19.72
STE:
0.40
BSX:
0.44
STE:
3.87
BSX:
3.44
STE:
3.18
BSX:
2.88
STE:
$5.94B
BSX:
$21.00B
STE:
$2.63B
BSX:
$14.94B
STE:
$1.34B
BSX:
$5.68B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
STE vs. BSX — Risk / Return Rank
STE
BSX
STE vs. BSX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for STERIS plc (STE) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| STE | BSX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.64 | ||
| Sortino ratioReturn per unit of downside risk | +2.71 | ||
| Omega ratioGain probability vs. loss probability | 1.05 | 0.67 | +0.38 |
| Calmar ratioReturn relative to maximum drawdown | 0.14 | -0.89 | +1.04 |
| Martin ratioReturn relative to average drawdown | 0.28 | -1.59 | +1.88 |
Loading charts...
Drawdowns
STE vs. BSX - Drawdown Comparison
The maximum STE drawdown since its inception was -77.22%, smaller than the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for STE and BSX.
Loading charts...
Drawdown Indicators
| STE | BSX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -77.22% | -89.15% | +11.93% |
Max Drawdown (1Y)Largest decline over 1 year | -25.37% | -60.58% | +35.21% |
Max Drawdown (3Y)Largest decline over 3 years | -25.37% | -60.58% | +35.21% |
Max Drawdown (5Y)Largest decline over 5 years | -36.18% | -60.58% | +24.40% |
Max Drawdown (10Y)Largest decline over 10 years | -36.18% | -60.58% | +24.40% |
Current DrawdownCurrent decline from peak | -12.93% | -55.22% | +42.29% |
Average DrawdownAverage peak-to-trough decline | -18.32% | -38.84% | +20.52% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.82% | 33.93% | -21.11% |
Volatility
STE vs. BSX - Volatility Comparison
STERIS plc (STE) has a higher volatility of 10.80% compared to Boston Scientific Corporation (BSX) at 8.67%. This indicates that STE's price experiences larger fluctuations and is considered to be riskier than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| STE | BSX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.80% | 8.67% | +2.13% |
Volatility (6M)Calculated over the trailing 6-month period | 20.94% | 34.00% | -13.06% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.40% | 36.05% | -9.65% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.31% | 26.04% | +0.27% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.17% | 27.46% | -2.29% |
Dividends
STE vs. BSX - Dividend Comparison
STE's dividend yield for the trailing twelve months is around 1.08%, while BSX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSX Boston Scientific Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
STE STERIS plc | 1.08% | 0.95% | 1.06% | 0.90% | 0.97% | 0.68% | 0.81% | 0.93% | 1.22% | 1.35% | 1.57% | 1.27% |
Financials
STE vs. BSX - Financials Comparison
This section allows you to compare key financial metrics between STERIS plc and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
STE vs. BSX - Profitability Comparison
STE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, STERIS plc reported a gross profit of 697.10M and revenue of 1.59B. Therefore, the gross margin over that period was 43.9%.
BSX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Boston Scientific Corporation reported a gross profit of 3.85B and revenue of 5.44B. Therefore, the gross margin over that period was 70.7%.
STE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, STERIS plc reported an operating income of 316.80M and revenue of 1.59B, resulting in an operating margin of 19.9%.
BSX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Boston Scientific Corporation reported an operating income of 1.18B and revenue of 5.44B, resulting in an operating margin of 21.7%.
STE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, STERIS plc reported a net income of 220.30M and revenue of 1.59B, resulting in a net margin of 13.9%.
BSX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Boston Scientific Corporation reported a net income of 907.00M and revenue of 5.44B, resulting in a net margin of 16.7%.
Frequently Asked Questions
STE and BSX have a correlation of 0.38, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
STE has higher volatility (10.80%) compared to BSX (8.67%). In terms of maximum drawdown, STE dropped -77.22% vs BSX's -89.15%.
STE currently has the higher Sharpe Ratio (0.14 vs -1.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for STE and BSX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer